J Cancer Res Clin Oncol

J Cancer Res Clin Oncol

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

582

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 582 Papers
Advances in the antitumor mechanisms of tripartite motif-containing protein 3.

Teng W, Ling Y, Liu Z, Jiang L, Fu G, Zhou X, Long N, Liu J, Chu L.

2024 PMID: 38411731
3/7
COI Funding
A novel EIF3C-related CD8<sup>+</sup> T-cell signature in predicting prognosis and immunotherapy response of nasopharyn…

Li R, Wang Y, Wen X, Cheng B, Lv R, Chen R, Hu W, Wang Y, Liu J, Lin B, Zhang H, Zhang E, Tang X.

2024 PMID: 38400862
4/7
Data COI Funding
COI Funding
Approved immune checkpoint inhibitors in hepatocellular carcinoma: a large-scale meta-analysis and systematic review.

Zhang R, Wang F, You Z, Deng D, He J, Yan W, Quan J, Wang J, Yan S.

2024 PMID: 38319412
3/7
COI Funding
COI Funding
A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent ch…

Zhong N, Yu D, Yang M, Lu X, Zhang Q, Wei W, Jiao J, Yang X, Zhu Z, Chen S, Xiao J.

2024 PMID: 38369555
4/7
Data COI Funding
A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MR…

Wei R, Lu S, Lai S, Liang F, Zhang W, Jiang X, Zhen X, Yang R.

2024 PMID: 38305926
3/7
COI Funding
A visualization analysis of hotspots and global trends on pelvic floor dysfunction in cervical cancer.

Wang J, Wang X, Ma T, Lu Y, Yan Z, Wang J, Hao Q.

2024 PMID: 38289495
3/7
COI Funding
BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pl…

Yuce TH, Ak G, Metintas S, Dundar E, Roe OD, Panou V, Metintas M.

2024 PMID: 38280040
3/7
COI Funding
Bioinformatics analysis of GPS1 expression and biological function in breast cancer.

Wei H, Niu Z, Ji R, Jiang W, Tang J, Meng Z, Cao X, Zhang X, Liu X.

2024 PMID: 38289496
3/7
COI Funding